Results 271 to 280 of about 200,296 (309)
Some of the next articles are maybe not open access.

Cas9 gets a classmate

Nature Biotechnology, 2015
Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.
Erik J, Sontheimer, Scot A, Wolfe
openaire   +2 more sources

CRISPR/Cas9-NHEJ

ACM SIGGRAPH 2018 Posters, 2018
CRISPR/Cas9-NHEJ: Action in the Nucleus (2017) is derived from an interdisciplinary creative process. This paper discusses the creation of this 210° scientific visualization, the usage of data from the worldwide Protein Data Bank, and the audio-visual presentation in an interactive dome setup.
Martina R. Fröschl, Alfred Vendl
openaire   +1 more source

CRISPR Cas9 − Licensing the unlicensable

Journal of Biotechnology, 2018
A new gene engineering technology has recently made it through the media, not only because of its technical advantages, but also because it is in the focus of an epic patent battle between two academic institutions. The technology bears the cryptic name "CRISPR Cas9", and allows the manipulation of genes (so called "gene editing") with so far unseen ...
openaire   +2 more sources

The final cut: Cas9 editing

Nature Structural & Molecular Biology, 2019
The ability of CRISPR-Cas9 to accurately and efficiently target and cleave any segment of double-stranded DNA based solely on the sequence of its loaded guide RNA has revolutionized genome editing. While many structural studies have shed light on the atomic details of DNA targeting, structures of the enzyme poised to perform catalysis have remained ...
openaire   +2 more sources

Cas9 in close-up

Nature Biotechnology, 2014
Erin L, Garside, Andrew M, MacMillan
openaire   +2 more sources

Cas9

2022
openaire   +1 more source

CRISPR/Cas9

2021
Parul Sharma, Rajnish Sharma
openaire   +1 more source

Structural basis for Cas9 off-target activity

Cell, 2022
Katja Bargsten, Martin Jinek
exaly  

Home - About - Disclaimer - Privacy